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Background and purpose — Very little has been published on the 
outcome of femoral cemented revisions using a third-generation 
cementing technique. We report the medium-term outcome of a 
consecutive series of patients treated in this way.
Patients and methods — This study included 92 consecutive 
cemented femoral revisions performed in our department with a 
third-generation cementing technique and without instrumented 
bone impaction grafting between 1996 and 2007. The average 
age of the patients at revision was 66 (25–92) years. None of the 
patients were lost to follow-up. At review in December 2013, 55 
patients were still alive and had a non-re-revised femoral revision 
component in situ after a mean follow-up of 11 (5–17) years.
Results — The mean preoperative Harris hip score was 50, and 
improved to 73 at final follow-up. 2 patients died shortly after the 
revision surgery. 1 stem was re-revised for aseptic loosening; this 
was also the only case with radiolucent lines in all 7 Gruen zones. 
A femoral reoperation was performed in 19 hips during follow-
up, and in 14 of these 19 reoperations the femoral component was 
re-revised. Survivorship at 10 years, with femoral re-revision for 
any reason as the endpoint, was 86% (95% CI: 77–92). However, 
excluding 8 patients with reinfections after septic index revisions 
and 1 with hematogenous spread of infection from the survival 
analysis, the adjusted survival for re-revision for any reason at 10 
years was 92% (95% CI: 83–96). With re-revision for aseptic loos-
ening as endpoint, the survival at 10 years was 99% (CI: 90–100).
Interpretation — Femoral component revision with a third-
generation cemented stem results in acceptable survival after 
medium-term follow-up. We recommend the use of this technique 
in femoral revisions with limited loss of bone stock. 

Outcome reports of cemented revisions of failed total hip 
arthroplasties (THAs) published before 1985 were not encour-
aging (Amstutz et al. 1982, Kavanagh et al. 1985, Pellicci et 
al. 1985). However, once better cementing techniques became 
available, the results of revisions on the femoral side remark-
ably improved. Proper preparation of the femoral canal with 
complete cement removal, placement of a distal cement plug, 
and optimal pressurization of an adequate amount of cement 
are essential steps for improvement of the outcome of femoral 
cemented revision.
As a result of these improvements in cementing technique, 
studies investigating the use of these modern cementing meth-
ods in patient cohorts ranging in size from 34 to 399 hips have 
shown encouraging medium- to long-term results (Raut et al. 
1996, Gramkow et al. 2001, Haydon et al. 2004, Howie et al. 
2007, So et al. 2013) However, the outcome of femoral revi-
sions using a third-generation cementing technique (which 
comprises pulsatile bone lavage, the use of a distal intramed-
ullary plug, retrograde injection of vacuum-mixed low-viscos-
ity cement with a cement gun, and solid pressurization) is still 
poorly documented. Only 2 groups have reported their results: 
1 study was based on 34 hips after a mean follow-up of 11.3 
years and all the stems used were long (So et al. 2013), and the 
other group reported the results of 83 hips after a mean of 3.6 
years (Eisler et al. 2000).
We analyzed the clinical and radiographic outcome, survi-
vorship, and complication rate of all 92 consecutive cemented 
femoral revisions performed with a third-generation cement-




All surgeries were performed between January 1996 and 
December 2007. All data were collected prospectively.
The inclusion process for this study is shown in Figure 1. 
At our institution, we use cemented femoral components in 
all revision cases. However, when there is femoral bone stock 
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 loss preoperatively or intraoperatively, we generally use the 
femoral bone impaction grafting technique to reconstruct 
these defects (Schreurs et al. 2006). All these femoral revi-
sions, combining cement and bone impaction grafting, were 
excluded from the current study. We also excluded cement-
in-cement femoral revisions. All 92 “cement-only” femoral 
reconstructions were included in this study. Osteoarthritis 
was the most common reason for the primary arthroplasty and 
aseptic loosening was the most common reason for the revi-
sion (Table 1). These 92 femoral revisions were performed in 
90 patients (58 of them women) with a mean age of 66 (25–92) 
years. The average weight of the patients was 73 (40–116) kg, 
their average height was 168 (147–198) cm, and their average 
body mass index (BMI) was 26 (15–44).
The index femoral revision was the first in 79 of the cases, 
the second in 11, and the third in 2. In 69 hips, the surgery per-
formed was a revision of both components of the THA, in 10 
hips only the stem of the THA was revised, and in the remain-
ing 13 hips a conversion of a hemiarthroplasty to THA with 
exchange of the femoral component was performed. 87 of the 
92 revision operations were performed by 1 of the 2 senior 
faculty surgeons (JWMG and BWS). 25 of the 29 hips with 
septic loosening were treated with a 2-stage procedure, using 
systemic antibiotics to eradicate the infecting organism for 
at least 6 weeks before reimplantation. The diagnosis septic 
loosening in the remaining 4 hips was based postoperatively 
on bacterial cultures taken during a 1-stage revision for pre-
sumed aseptic loosening.
Because many infections that occurred during follow-up 
after a septic index revision were multi-microbial, in most 
cases it was impossible to state whether this was a new infec-
tion with a different organism or a persistent infection with 
the same organism. We therefore used the following definition 
of reinfection in this study: all infections (persistent infection 
with the same organism, infection with a new organism, or 
multi-microbial infection) in a patient who was included in the 
study with a septic index revision.
Surgical technique
The posterolateral approach was used in all patients. All revi-
sion femoral components were inserted using a third-generation 
cementing technique with pulsatile lavage, a distal intramedul-
lary plug, retrograde injection of vacuum-mixed low-viscosity 
cement with a cement gun, and solid pressurization. The com-
ponents used were 78 normal-length femoral components: 76 
Exeter stems (Stryker-Howmedica, Newbury, UK), 1 Muller 
straight stem (Sulzer, Wintherthur, Switzerland), and 1 Charn-
ley Elite femoral component (DePuy, Leeds, UK). In addition, 
13 long Exeter femoral components with a length of 205 mm 
or more and 1 Exeter short revision stem were used. The metal 
femoral heads had a diameter of 22.2 mm in 1 patient, 28 mm 
in 65 patients, and 32 mm in 26 patients. Simplex bone low-
viscosity cement (Stryker-Howmedica, Newbury, UK) loaded 
with erythromycin and colistin was used in all cases.
Aftercare
Patients were mobilized under the supervision of a physio-
therapist 1 or 2 days after surgery using 2 crutches, and full 
weight bearing immediately allowed. This protocol was modi-
fied for some patients who also had an acetabular reconstruc-
tion, depending on the type and extent of the defect and recon-
struction.
The postoperative regimen included systemic antibiotics (3 
intravenous doses of 1g cefazolin) for 1 day and indometha-
cin for 7 days to prevent heterotopic ossification. All patients 
received anticoagulation with Coumadin (warfarin) or low-
molecular-weight heparin for venous thromboembolism pro-
phylaxis for a minimum of 6 weeks.
Figure 1. The flow chart showing the identification of eligible patients for the study. a Proxi-
mal femoral replacement prosthesis placed for oncologic reasons or because the bone 




Excluded (n = 207):
– femoral bone impaction grafting, 176
– femoral cement-in-cement technique, 33
– proximal femoral replacement prosthesis a, 8
Lost to clinical follow-up (n = 0)
Incomplete radiographic follow-up (n = 16)
Cemented femoral revisions
n = 92
Functioning at final review




Table 1. Original indications for the 92 primary 
THAs/hemiarthroplasties and revisions
  n 
Indications for the primary THAs/
hemiarthroplasties 
 Primary osteoarthritis 31 
 Congenital hip dysplasia 15 
 Trauma 16 
 Rheumatoid arthritis 11 
 Osteonecrosis 8 
 Miscellaneous 4 
 Unknown 7 
Indications for the revisions 
 Aseptic loosening 44 
 Septic loosening 29 
 Dislocation 6 
 Malposition of femoral component 6 
 Ankylosis 3 
 Protrusion of head, hemiarthroplasty 2 
 Trauma 2 
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Clinical evaluation
A standard postoperative follow-up protocol was used, with 
physical and radiographic examination at 6 weeks, 3 months, 
6 months, and 1 year, and then on an annual or biannual basis.
Clinical evaluation was performed using the Harris hip score 
(HHS: worst score 0; best score 100), the Oxford hip scores 
(OHS: worst score 60; best score 12) (Dawson et al. 1996), 
visual analog scales (VAS) (Brokelman et al. 2012) for pain at 
rest and during physical activity on a scale from 0 (no pain) to 
100 (unbearable pain), and a VAS for satisfaction on a scale 
from 0 (not satisfied at all) to 100 (complete satisfaction). 
Radiographic evaluation
Anteroposterior radiographs taken during the last follow-up 
were evaluated and compared with earlier postoperative and 
preoperative radiographs. The radiographs were scored by 2 
of the authors (MTS and BWS) by consensus. Bone stock loss 
was determined on preoperative radiographs and on the basis 
of the intraoperative findings, and was classified according to 
the system of the Endoklinik (Engelbrecht and Heinert 1987) 
as grade 1 in 70 hips, grade 2 in 9, grade 3 in 12, and grade 4 
in 1. To determine the stem migration, we used a method as 
described by Fowler et al. (1988); radiolucencies (complete 
radiolucent lines ≥ 2 mm in width) were scored with use of 
the classification system of Gruen. Radiographic failure was 
defined as a circumferential radiolucent line in all 7 Gruen 
zones on an anteroposterior view.
Statistics
We performed a Kaplan-Meier survivorship analysis, includ-
ing determination of 95% confidence intervals (CIs), using 
femoral re-revision for any reason and re-revision for aseptic 
loosening, femoral reoperation for any reason, and subsidence 
of ≥ 5 mm as the endpoints. Comparisons of the survival of the 
different Endoklinik groups, and of the standard stems and the 
long stems, were performed with the log-rank test. We used 
the Wilcoxon signed rank test to compare the preoperative and 
postoperative HHS and OHS.
Analysis of the data was carried out using Graphpad Prism 
software version 5.03 (Graphpad Software Inc., La Jolla, 
CA).
Ethics
This study was approved by our institutional review board. 
Results
Clinical results
The mean preoperative HHS was 50 (29–90), and it improved 
to 73 (14–100) at final follow-up (p = 0.01). The mean preop-
erative OHS was 37 (25–53), and it improved to 25 (12–48) (p 
= 0.007). At last follow-up , the mean VAS score for satisfac-
tion was 77 (15–100), the mean VAS score for pain at rest was 
15 (0–80), and the mean VAS score for pain during exercise 
was 21 (0–90).
Intraoperative complications 
1 intraoperative femoral fracture occurred during a full-length 
transfemoral Wagner osteotomy to remove an uncemented 
stem. This fracture was treated with plate fixation and cables.
Early postoperative deaths
2 patients died within 2 weeks after revision surgery. Both 
were octogenerians and had an ASA classification of grade 3. 
The first patient was admitted to our hospital after a fall, which 
caused a Vancouver type-B2 fracture. The patient developed 
lung edema during surgery and died on the first postoperative 
day. The second patient was admitted for unbearable pain due 
to protrusion of a hemiarthroplasty. The patient had conges-
tive heart failure before surgery and died 13 days after surgery, 
due to cardiac failure.
Femoral reoperations and re-revisions 
In 19 hips, a femoral reoperation was performed during fol-
low-up, and in 14 of these 19 reoperations the femoral compo-
nent was re-revised. The main reasons for these femoral reop-
erations were infection (n = 13) and periprosthetic fracture (n 
= 3) (Table 2). 
Survivorship
The survival of the femoral component with re-revision for 
any reason as the endpoint was 86% (95% CI: 77–92) at 10 
years. With femoral re-revision for aseptic loosening as the 
endpoint, the survival at 10 years was 99% (CI: 9–100), and 
with femoral reoperation for any reason as the endpoint it was 
79% (CI: 68–86). With a subsidence of the femoral compo-
nent of ≥ 5 mm as the endpoint, the survival was 98% (CI: 
91–99) (Figure 2). 
No statistically significant differences in outcomes could be 
detected between the various Endoklinik categories of bone 
stock loss and between stem lengths.
Finally, we performed a sensitivity analysis to assess the 
effect of the bilateral hips in 2 patients. When we excluded 
these 4 hips from our survivorship analysis, the survival of 
the femoral component at 10 years with re-revision for any 
reason as the endpoint was similar to the survival outcome in 
the complete patient group.
Postoperative periprosthetic fractures 
A reoperation for plate fixation of a postoperative peripros-
thetic femoral fracture was performed in 3 patients (nos. 12, 
17, and 18 in Table 2). 
Postoperative infections 
A femoral reoperation and/or re-revision was performed in 13 
patients for septic reasons (patients 2–10 and 13–16 in Table 
2). However, 8 of these 13 patients had reinfections after 
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 septic index revisions and 1 had a hema-
togenous spread of infection (originating 
from an infected open ankle fracture; 
patient 3 in Table 2). When we excluded 
these 9 patients from the survival analy-
sis, the adjusted survival for re-revision 
for any reason at 10 years was 92% (CI: 
83–96), while the survival for reopera-
tion for any reason was 89% (CI: 79–94).
Dislocations
Dislocations occurred in 12 patients. 9 of 
these were treated nonoperatively and a 
reoperation was performed in 3 patients: 
in 1 patient a re-revision of only the ace-
tabular component was performed, in 1 a 
Trident constrained liner (Stryker-How-
medica, Newbury, UK) was implanted, 
and in the last patient (no. 11 in Table 2) 
the femoral component was reimplanted 
1.5 cm higher using a cement-in-cement 
technique. 1 patient had the femoral head 
exchanged for one with a larger offset.
Table 2. 19 hips with 1 or more femoral reoperations. In 14 of these cases, a re-revision of the femoral component was performed
Case Revision indication  First femoral re-revision/reoperation FU a Later femoral re-revision/reoperation FU a
Femoral component re-revised
 1 Septic loosening Loosening of cup + femoral mismatch 14.1  
 2 Malpositioning of stem Debridement for infection b 2.6 Permanent excision arthroplasty 4.7
 3 Aseptic loosening Refixation pseudoarthrosis, greater trochanter 9.1 Two-stage re-revision for infection 
     (hematogenous spread after open 
     ankle fracture) d 10.1
 4 Aseptic loosening Permanent excision arthroplasty for infection b 2.7  
 5 Septic loosening Two-stage re-revision for infection c 2.1  
 6 Malpositioning of stem Permanent excision arthroplasty for infection b 4.1  
 7 Septic loosening Permanent excision arthroplasty for infection c 1.6  
 8 Septic loosening Permanent excision arthroplasty for infection c 1.1  
 9 Septic loosening Permanent excision arthroplasty for infection c 3.8  
 10 Septic loosening Two-stage revision for infection c 2.6  
 11 Recurrent dislocations Femoral component reimplanted 1.5 cm
   higher for recurrent dislocations 0.8  
 12 Septic loosening Plate fixation, spontaneous periprosthetic fracture 3.8 Re-revision of femoral component for 
     pseudoarthrosis, periprosthetic fracture 4.7
 13 Aseptic loosening Debridement for infection b 0.1 Re-revision for aseptic loosening 6.2
 14 Septic loosening Permanent excision arthroplasty for infection c 0.5  
Femoral component retained
 15 Septic loosening Debridement for infection c 0.1  
 16 Septic loosening Debridement for infection c 0.1  
 17 Aseptic loosening Plate fixation, periprosthetic fracture after fall 0.6  
 18 Aseptic loosening Plate fixation, periprosthetic fracture after fall 5.8  
 19 Septic loosening Reconstruction of fissure greater trochanter
   during cup revision 0.6
  
a FU: follow-up in years from index femoral revision.
b new infection; 
c reinfection after a previous septic index revision; 
d hematogenous spread of infection
Figure 2. Kaplan-Meier survival curves with re-revision of the femoral component for any reason 
(A), aseptic loosening (B), femoral reoperation for any reason (C), or subsidence of ≥ 5 mm (D) 
as the endpoint.
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 Radiographic results
Radiographic follow-up was complete in 76 revisions (Figure 
3), and in 16 revisions some radiographs during follow-up 
were missing. Even so, we could include these patients in 
the analysis. Radiolucent lines were observed in 24 hips. 11 
patients had radiolucent lines in 1 Gruen zone, 8 patients in 2 
zones, and 5 patients in 3 or more zones. In 18 of the 24 hips, 
these radiolucent lines were progressive. The femoral compo-
nent which was re-revised for aseptic loosening was the only 
one with radiolucent lines in all 7 zones. The mean amount of 
subsidence of all femoral components was 1.5 (range 0–23) 
mm. 2 femoral components had subsided by ≥ 5 mm (13 and 
23 mm).
Discussion
With a 10-year survivorship of 99% for the endpoint re-revi-
sion for aseptic loosening, our study shows that satisfying 
results can be obtained in femoral revisions using a third-gen-
eration cementing technique.
The 10-year survivorship of 86% for the endpoint re-revi-
sion for any reason, and 79% for the endpoint reoperation for 
any reason, are considerably less favorable than the survival 
for aseptic loosening. The reason for this could be that we 
are a tertiary referral center for the treatment of periprosthetic 
joint infections, and a considerable proportion of the index 
femoral revisions performed were septic revisions (29 of 92 
cases). When we excluded the 8 patients with reinfections after 
septic index revisions and the 1 patient with hematogeneous 
prospective, randomized study by Garbuz et al. (2012) com-
paring dislocation rates between revision THAs performed 
using 36-mm and 40-mm heads with those performed with a 
32-mm head found a dislocation rate of 1% with 36-mm/40-
mm heads and 8.7% with a 32-mm head. Their study was 
prematurely terminated in light of these stunning findings. 
Nevertheless, stability advantages in increasing the head 
diameter beyond 38–40 mm have not been clearly demon-
strated (Rodriguez and Rathod 2012).
As mentioned earlier, where there is preoperative or intra-
operative loss of femoral bone stock, we generally choose 
to perform femoral bone impaction grafting to reconstruct 
these defects, combined with a cemented stem (Schreurs et 
al. 2006). Recent studies from several centers have shown that 
this femoral bone impaction grafting technique can be reward-
ing in femoral revision cases with bone stock loss (Ornstein et 
al. 2009, Garcia-Cimbrelo et al. 2011, Lamberton et al. 2011, 
Te Stroet et al. 2012, Garvin et al. 2013) (Table 3, see Sup-
plementary data). Excellent survival rates have been reported 
with re-revision for aseptic loosening as the end point, gener-
ally with a survival of greater than 98%. Despite this superior 
technique, we sometimes choose to perform a cemented revi-
sion without bone impaction grafting even in case of extensive 
femoral bone defects in weak or very old patients. In the cur-
rent study, 13 of the 92 patients had a preoperative Endoklinik 
score of 3 or more and would normally have had a bone impac-
tion grafting—but did not get it because of their weak physical 
condition and/or very old age. No significant differences in the 
outcomes could be detected between the various Endoklinik 
groups in our study.
Figure 3. A. A 43-year-old woman at presentation with a loose cemented hemiarthroplasty 
with protrusion of the head. B. Directly after the conversion to a total hip arthroplasty (the 
acetabulum was reconstructed with metal meshes and bone impaction bone). C. 11 years 
postoperatively, showing a stable femoral and acetabular component without any signs of 
loosening.
  A   B   C
spread of infection from the survival analy-
sis, the adjusted survival for re-revision for 
any reason at 10 years was 92%, while the 
survival for reoperation for any reason was 
89%. Our survival rates are comparable to 
those reported in other series (Raut et al. 
1996, Gramkow et al. 2001, Haydon et al. 
2004, Howie et al. 2007, So et al. 2013) 
(Table 3, see Supplementary data).
Our dislocation rate of 13% is high, but 
is similar to the 11% found by Alberton 
et al. (2002) in a review of the literature 
that covered 26 reports describing 211 
dislocations (11%, range: 0–54%) after 
1,856 revision procedures. Also, Howie 
et al. (2007) found a high dislocation rate 
of 14% after 6 years of follow-up. How-
ever, in all these studies most of the fem-
oral heads used were 32 mm or smaller. 
Recent large register studies on primary 
THAs have shown that the use of larger 
femoral heads reduces the number of dis-
locations (Jameson et al. 2011, Kostensalo 
et al. 2013). In addition to this, a recent 
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 Another promising option for the revision of loose femoral 
components is the use of uncemented stems. Recent studies 
of uncemented stems with several different fixation mecha-
nisms have shown survival outcomes ranging from 92% to 
100% after medium-term follow-up (Adolphson et al. 2009, 
Muirhead-Allwood et al. 2010, Amanatullah et al. 2011, Regis 
et al. 2011, Thomsen et al. 2013) (Table 3, see Supplemen-
tary data). However, possible drawbacks of using these unce-
mented components are extensive stress shielding (Adolphson 
et al. 2009, Thomsen et al. 2013) and subsidence (Regis et 
al. 2011). Long-term results will have to prove whether these 
findings can lead to complications such as loosening or frac-
tures.
In summary, the results of cemented femoral component 
revisions show acceptable survival at medium-term follow-up. 
We recommend the use of this technique in femoral revisions 
with limited loss of bone stock and in patients who cannot 
tolerate more extensive surgery with bone grafting due to their 
physical condition and/or very old age. When a femoral revi-
sion must be performed in a younger patient with extensive 
loss of bone stock, we recommend bone impaction grafting 
using the instrumented X-change revision system (Schreurs et 
al. 2006, Te Stroet et al. 2012).
Supplementary data
Table 3 is available on the Acta Orthopaedica website, www.
actaorthop.org, identification number 8203.
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